The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma

Claudio Festuccia(University of L'Aquila), Thomas Mehrling

Journal of Hematology & Oncology

February 27, 2018

10.1186/s13045-018-0576-6

Cited by 57

Related Papers

Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models

|Endocrine Related Cancer|2009|67

The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties

|Frontiers in Pharmacology|2020|28

Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer

|Oncotarget|2017|20